Additionally, due to the potential role of hypercoagulability in CUA pathogenesis [34], tissue plasminogen activator (TPA) has been used in some small observational studies and case reports [35]; in conjunction with aggressive wound care, debridement, infection control, and optimization of calcium–phosphate homeostasis. This evidence concerns the gene PLAT and infection.